[1] The Dutch-Finnish Ozone Monitoring Instrument (OMI) on board the NASA EOS Aura spacecraft is a nadir viewing spectrometer that measures solar reflected and backscattered light in a selected range of the ultraviolet and visible spectrum. The instrument has a 2600 km wide viewing swath and it is capable of daily, global contiguous mapping. The Finnish Meteorological Institute and NASA Goddard Space Flight Center have developed a surface ultraviolet irradiance algorithm for OMI that produces noontime surface spectral UV irradiance estimates at four wavelengths, noontime erythemal dose rate (UV index), and the erythemal daily dose. The overpass erythemal daily doses derived from OMI data were compared with the daily doses calculated from the ground-based spectral UV measurements from 18 reference instruments. Two alternative methods for the OMI UV algorithm cloud correction were compared: the plane-parallel cloud model method and the method based on Lambertian equivalent reflectivity. The validation results for the two methods showed some differences, but the results do not imply that one method is categorically superior to the other. For flat, snow-free regions with modest loadings of absorbing aerosols or trace gases, the OMI-derived daily erythemal doses have a median overestimation of 0-10%, and some 60 to 80% of the doses are within ±20% from the ground reference. For sites significantly affected by absorbing aerosols or trace gases one expects, and observes, bigger positive bias up to 50%. For high-latitude sites the satellite-derived doses are occasionally up to 50% too small because of unrealistically small climatological surface albedo.
The diurnal and annual variability of solar UV radiation in Europe is described for different latitudes, seasons and different biologic weighting functions. For the description of this variability under cloudless skies the widely used one-dimensional version of the radiative transfer model UVSPEC is used. We reconfirm that the major factor influencing the diurnal and annual variability of UV irradiance is solar elevation. While ozone is a strong absorber of UV radiation its effect is relatively constant when compared with the temporal variability of clouds. We show the significant role that clouds play in modifying the UV climate by analyzing erythemal irradiance measurements from 28 stations in Europe in summer. On average, the daily erythemal dose under cloudless skies varies between 2.2 kJ m(-2) at 70 degrees N and 5.2 kJ m(-2) at 35 degrees N, whereas these values are reduced to 1.5-4.5 kJ m(-2) if clouds are included. Thus clouds significantly reduce the monthly UV irradiation, with the smallest reductions, on average, at lower latitudes, which corresponds to the fact that it is often cloudless in the Mediterranean area in summer.
The UV Index was established more than 20 years ago as a tool for sun protection and health care. Shortly after its introduction, UV Index monitoring started in several countries either by newly acquired instruments or by converting measurements from existing instruments into the UV Index. The number of stations and networks has increased over the years. Currently, 160 stations in 25 European countries deliver online values to the public via the Internet. In this paper an overview of these UV Index monitoring sites in Europe is given. The overview includes instruments as well as quality assurance and quality control procedures. Furthermore, some examples are given about how UV Index values are presented to the public. Through these efforts, 57% of the European population is supplied with high quality information, enabling them to adapt behaviour. Although health care, including skin cancer prevention, is cost-effective, a proportion of the European population still doesn't have access to UV Index information.
Vitamin D3 photosynthesis in the skin is formulated as a set of reaction equations, including side-reactions to lumisterol, tachysterol and toxisterols, and the accompanying reverse reactions, isomerisation of previtamin D3 to vitamin D3 and photodegradation of vitamin D3. The solution of this set is given for the stationary irradiance spectrum. The effective action spectrum for the instantaneous vitamin D3 production changes shape as a function of exposure, and therefore, no single action spectrum can be used. We assessed the action spectrum for unexposed skin and for skin that has been exposed to 7.5 Standard Erythemal Doses (SED). We constructed two new estimates: (1) the RIVM action spectrum, based on absorption spectra, quantum yields and skin transmission spectra, and (2) the modified QUT action spectrum, which is adjusted for self-absorption and skin transmission. For previously unexposed skin, the modified QUT action spectrum gives a qualitatively similar, but larger estimate than the RIVM action spectrum. We have not been able to solve the lack of quantitative agreement between the vitamin D production estimates from the three action spectrum estimates (RIVM, modified QUT and CIE). All new action spectra have stronger emphasis on the short wavelengths than the CIE action spectrum. We showed that, for wavelengths larger than 300 nm, the bandwidth that was used in the experiment that formed the basis of the CIE action spectrum, gives a red-shift of about 1 nm. Generally, with the formation of previtamin D3, the return reaction to provitamin D3 limits the production of vitamin D3. After some exposure, the new action spectrum has negative values for the longer wavelengths in the UVB. For the RIVM action spectrum, this happens after 7.5 SED, for the modified QUT action spectrum already after 1.25 SED, and after 7.5 SED the net production rate is largely cancelled. Thus prolonged exposure of previously unexposed skin saturates vitamin D3 formation. For maximum vitamin D production after 1.25 SED, sunscreens should block wavelengths larger than 310 nm. Sunscreens that block only UVB could result in reduction in vitamin D production after prolonged exposure, or even a destruction of vitamin D that has just been formed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.